Cranial ultrasound in metabolic disorders presenting in the neonatal period: characteristic features and comparison with MR imaging.
OBJECTIVE
Brain imaging is an integral part of the diagnostic work-up for metabolic disorders, and the bedside availability of cranial ultrasonography (cUS) allows very early brain imaging in symptomatic neonates. Our aim was to investigate the role and range of abnormalities seen on cUS in neonates presenting with metabolic disorders. A secondary aim, when possible, was to address the question of whether brain MR imaging is more informative by comparing cUS to MR imaging findings.


METHODS
Neonates with a metabolic disorder who had at least 1 cUS scan were eligible. cUS images were reviewed for anatomic and maturation features, cysts, calcium, and other abnormalities. When an MR imaging scan had been obtained, both sets of images were compared.


RESULTS
Fifty-five infants (35 also had MR imaging) were studied. The most frequent findings were in oxidative phosphorylation disorders (21 cUS and 12 MR imaging): ventricular dilation (11 cUS and 6 MR imaging), germinolytic cysts (GLCs; 7 cUS and 5 MR imaging), and abnormal white matter (7 cUS and 6 MR imaging); in peroxisomal biogenesis disorders (13 cUS and 9 MR imaging): GLCs (10 cUS and 6 MR imaging), ventricular dilation (10 cUS and 5 MR imaging), abnormal cortical folding (8 cUS and 7 MR imaging), and lenticulostriate vasculopathy (8 cUS); in amino acid metabolism and urea cycle disorders (14 cUS and 11 MR imaging): abnormal cortical folding (9 cUS and 4 MR imaging), abnormal white matter (8 cUS and 8 MR imaging), and hypoplasia of the corpus callosum (7 cUS and 6 MR imaging); in organic acid disorders (4 cUS and 2 MR imaging): periventricular white matter echogenicity (2 cUS and 1 MR imaging); and in other disorders (3 cUS and 1 MR imaging): ventricular dilation (2 cUS and 1 MR imaging). cUS findings were consistent with MR imaging findings. cUS was better for visualizing GLCs and calcification. MR imaging was more sensitive for subtle tissue signal intensity changes in the white matter and abnormality in areas difficult to visualize with cUS, though abnormalities of cortical folding suggestive of polymicrogyria were seen on cUS.


CONCLUSIONS
A wide range of abnormalities is seen using cUS in neonatal metabolic disorders. cUS is a reliable bedside tool for early detection of cysts, calcium, structural brain abnormalities, and white matter echogenicity, all suggestive of metabolic disorders.
Leijser
L M
LM
Department of Paediatrics and Neonatal Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom.
de Vries
L S
LS
Rutherford
M A
MA
Manzur
A Y
AY
Groenendaal
F
F
de Koning
T J
TJ
van der Heide-Jalving
M
M
Cowan
F M
FM
D001921:Brain / Q000473:pathology*; D001927:Brain Diseases / Q000150:complications / Q000175:diagnosis*; D004453:Echoencephalography / Q000379:methods*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008659:Metabolic Diseases / Q000150:complications / Q000175:diagnosis*; D015997:Neonatal Screening / Q000379:methods; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
J Comput Assist Tomogr. 2005 Jul-Aug;29(4):524-7
16012312
Clin Pediatr (Phila). 1999 Feb;38(2):77-86
10047940
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1996 Mar-Apr;37(2):96-102
8935406
Neurology. 2000 Feb 8;54(3):754-6
10680820
Ultrasound Obstet Gynecol. 2002 Dec;20(6):616-9
12493053
J Comput Assist Tomogr. 2004 Jan-Feb;28(1):93-7
14716239
J Neurol Neurosurg Psychiatry. 1998 Aug;65(2):233-40
9703178
J Child Neurol. 2001 Aug;16(8):608-13
11510937
Eur J Pediatr. 1994 Jul;153(7):510-6
7957369
Pediatr Neurol. 1990 Sep-Oct;6(5):326-9
2242175
AJNR Am J Neuroradiol. 2003 Aug;24(7):1471-4
12917150
Pediatr Radiol. 2006 Jul;36(7):636-46
16770668
Ment Retard Dev Disabil Res Rev. 2005;11(1):52-60
15856443
J Pediatr. 2002 Sep;141(3):429-31
12219068
Neuropediatrics. 1999 Apr;30(2):93-5
10401692
Neuroradiology. 2004 Jan;46(1):3-14
14605787
J Neurol Sci. 2002 Mar 30;195(2):171-5
11897250
Arch Dis Child Fetal Neonatal Ed. 1995 Sep;73(2):F55-61
7583607
Arch Dis Child. 1990 Jul;65(7 Spec No):670-1
2201267
Neuropediatrics. 2005 Jun;36(3):193-9
15944905
Circulation. 1999 Apr 27;99(16):2070-2
10217643
Pediatrics. 1998 Dec;102(6):E69
9832597
Early Hum Dev. 2006 Dec;82(12):827-35
17074450
AJNR Am J Neuroradiol. 1996 Feb;17(2):311-5
8938303
J Perinatol. 2000 Mar;20(2):120-8
10785889
Clin Dysmorphol. 2001 Apr;10(2):115-21
11310991
Clin Radiol. 2003 Nov;58(11):833-44
14581006
Neuropediatrics. 2004 Apr;35(2):113-9
15127310
AJNR Am J Neuroradiol. 2002 Aug;23(7):1095-100
12169463
Am J Med Genet. 1999 May 21;84(2):94-101
10323732
AJNR Am J Neuroradiol. 2002 Mar;23(3):480-3
11901023
Neuroradiology. 1998 Jun;40(6):347-54
9689620
Eur J Pediatr. 1994;153(7 Suppl 1):S90-3
7957395
Dev Med Child Neurol. 2000 Jun;42(6):414-7
10875529
Pediatr Radiol. 1995;25(4):256-8
7567229
Pediatr Res. 2002 Aug;52(2):292-300
12149509
AJNR Am J Neuroradiol. 1998 Feb;19(2):369-77
9504497
Pediatr Radiol. 2007 Jul;37(7):640-8
17486330
J Pediatr. 2003 Jun;142(6):647-55
12838193
AJNR Am J Neuroradiol. 1997 Jun-Jul;18(6):1163-70
9194444
J Inherit Metab Dis. 2004;27(2):275-6
15243982
Pediatr Neurol. 1994 May;10(3):244-6
8060429
J Clin Ultrasound. 2005 Jun;33(5):243-7
16047376
Neuroradiology. 2002 Jun;44(6):499-502
12070724
Acta Paediatr. 2006 Jan;95(1):6-14
16373289
Pediatr Radiol. 1995;25(4):254-5
7567228
Neuroradiology. 1991;33(6):478-93
1780048
Neuroradiology. 1990;32(1):56-9
2185434
J Pediatr. 2003 Mar;142(3):349-52
12640389
Pediatr Radiol. 1999 Feb;29(2):138-43
9933336